ATC code B
Source: Wikipedia, the free encyclopedia.
ATC code relating to drugs affecting the blood and blood forming organs
Pharmaceutical drug classification
ATC code B: Blood and blood forming organs |
---|
|
Other ATC codes |
ATC code B Blood and blood forming organs is a section of the
Codes for
ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code B". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QB". WHO Collaborating Centre for Drug Statistics Methodology.
Antiplatelet drugs |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
) | |||||||||||||||
Factor Xa inhibitors (with some II inhibition) |
| ||||||||||||||
Direct thrombin (IIa) inhibitors |
| ||||||||||||||
Other |
fibrinolytics
- r-tPA
- UPA
- Anistreplase
- Monteplase
- Streptokinase#
- Other serine endopeptidases: Ancrod‡
- Brinase
- Fibrinolysin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
Antihemorrhagics (coagulation) |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Antifibrinolytics |
|
Erythropoietins | |
---|---|
Iron supplements | |
folic acid supplements |
|
HIF prolyl-hydroxylase inhibitors | |
Other |
Blood substitutes and perfusion solutions (B05) | |
---|---|
Blood and related products (B05A) |
|
Intravenous solutions (B05B) |
|
Irrigating solutions (B05C) | |
Others (B05D, B05X) |
|
Other hematological agents (B06) | |
---|---|
Enzymes (B06AA) | |
Drugs used in hereditary angioedema (B06AC) |
|
Others |